Liver health and hormones in women: the real connection
Liver health and hormones are connected, but not in the simple "detox your oestrogen" way often sold online. The liver helps metabolise sex hormones and make hormone-binding proteins, while hormones influence insulin sensitivity, fat storage and the risk of fatty liver disease. For women, the most useful clinical links are menopause, PCOS, metabolic health, alcohol, medicines such as the combined pill or HRT, and whether liver blood tests or scans suggest a real liver condition.
Key facts
- The liver is an endocrine and metabolic organ. It helps process oestrogens, progesterone, androgens, thyroid hormones, bile acids, cholesterol and glucose.1
- Metabolic dysfunction-associated steatotic liver disease, still called NAFLD on many NHS pages, is more likely with type 2 diabetes, metabolic syndrome, PCOS, high blood pressure, high cholesterol and central weight gain.2
- Menopause is linked with higher odds of fatty liver in observational research, probably through oestrogen loss, visceral fat gain, insulin resistance and lipid changes rather than one hormone alone.5
- PCOS is a liver-health issue as well as a reproductive hormone issue because insulin resistance, low SHBG and higher androgens overlap with fatty liver risk.6
- Routine liver blood tests can miss fatty liver, so risk assessment may need ultrasound, fibrosis scoring or specialist review when risk factors are present.3
The two-way liver and hormone connection
The liver is not just a filter. It is a metabolic control centre that helps decide how the body handles sugar, fats, cholesterol, bile acids, medicines and hormones. It also produces sex hormone-binding globulin, usually shortened to SHBG, which binds oestradiol and testosterone in the blood and influences how much free hormone is available to tissues.1
This is why liver and hormone symptoms can overlap. Insulin resistance can reduce SHBG and raise free androgen exposure in some women. Lower oestrogen after menopause can shift fat distribution towards the abdomen, worsen lipids, reduce muscle mass and make fatty liver more likely. Liver inflammation or scarring can also disturb hormone metabolism, menstrual patterns, clotting proteins, energy, itch, sleep and appetite.
The trap is turning this real biology into one vague diagnosis. "Poor liver detox" is not a precise explanation for heavy periods, PMS, acne, weight gain or fatigue. Those symptoms can come from PCOS, thyroid disease, perimenopause, iron deficiency, medicines, alcohol or liver disease. A good assessment separates the hormone pattern from the liver pattern.
Evidence grade: the liver-hormone connection is strong as physiology. The weaker claim is that supplements can reliably "detox oestrogen" or normalise hormones without diagnosing metabolic, gynaecological, endocrine or liver disease.
Where the evidence is strongest
The clearest women-specific evidence is fatty liver disease. The older term is non-alcoholic fatty liver disease, or NAFLD. The newer term is metabolic dysfunction-associated steatotic liver disease, or MASLD. NHS pages still use NAFLD, and the practical point is the same: fat builds up in the liver in association with metabolic risk, and a smaller proportion of people progress to inflammation, fibrosis, cirrhosis or liver cancer.2
NICE says NAFLD is more common in people with type 2 diabetes or metabolic syndrome and advises taking an alcohol history because alcohol-related liver disease can look similar. NICE also states that routine liver blood tests should not be used to rule out NAFLD.3 More recent European MASLD guidelines also frame the condition as part of cardiometabolic risk, with obesity, type 2 diabetes, dyslipidaemia and hypertension central to assessment and follow-up.4
Menopause is one reason this matters for women. A 2023 systematic review and meta-analysis found that menopausal status was associated with higher odds of NAFLD: pooled odds ratio 2.37 across 12 cross-sectional studies, and 2.19 in sensitivity analyses adjusted for age and metabolic factors.5 This does not prove menopause alone causes fatty liver. It does support treating the menopause transition as a time to check cardiometabolic risk, waist change, blood pressure, lipids, glucose and liver risk, especially if symptoms or blood tests have changed.
PCOS is the other major link. A 2021 systematic review and meta-analysis in premenopausal women found PCOS was associated with an almost 2.5-fold higher risk of NAFLD compared with controls, across 23 studies including 4,164 PCOS cases and 2,984 matched controls.6 The likely drivers are not ovaries alone. Insulin resistance, central adiposity, triglycerides, low SHBG, higher free androgen exposure and inflammation all sit in the same network.
| Situation | Why it matters for the liver | Useful next step |
|---|---|---|
| PCOS with irregular periods, acne or excess hair growth | PCOS often overlaps with insulin resistance, lower SHBG and higher fatty liver risk. | Ask about HbA1c, lipids, blood pressure, waist measurement and liver risk, not just reproductive hormones. |
| Perimenopause or menopause with waist gain | Oestrogen loss, visceral fat gain and metabolic changes can raise MASLD risk. | Check cardiometabolic markers and consider liver assessment if risk factors or abnormal tests appear. |
| Raised ALT, AST, GGT or bilirubin | Abnormal liver blood tests need context, repeat testing and cause-finding, not supplement guessing. | Review alcohol, medicines, viral hepatitis risk, metabolic risk, pregnancy status and symptoms. |
| Starting combined hormonal contraception | Most healthy women can use it, but severe cirrhosis, liver cancer and some gallbladder or bile duct problems matter. | Tell the prescriber about liver disease, jaundice, gallbladder disease, migraines with aura, clot history and smoking. |
| Considering HRT | Liver disease may mean HRT is unsuitable or needs specialist advice, and route of delivery may matter. | Discuss liver history, clot risk, blood pressure, breast cancer history and whether transdermal options are more appropriate. |
| Heavy alcohol intake or regular binge drinking | Alcohol can raise liver enzymes, worsen fatty liver risk and complicate hormone symptoms such as sleep and mood changes. | Be honest about units per week and ask for help reducing safely if stopping suddenly may be difficult. |
Hormone medicines and liver safety
Hormone medicines are not automatically dangerous to the liver, but they are not irrelevant either. LiverTox notes that modern oestrogen-containing contraceptives and HRT are not usually linked with higher rates of routine ALT or alkaline phosphatase elevations than placebo, but oestrogens and oral contraceptives can rarely cause clinically apparent cholestatic liver injury, especially early in treatment, and have been linked with hepatic adenomas after longer exposure.7
The practical UK rule is disclosure, not panic. NHS guidance says the combined pill may not be suitable for people with gallbladder or bile duct problems, liver cancer or severe cirrhosis, and advises discussing safety with a doctor, nurse or pharmacist if those apply.8 NHS Inform says HRT may not be suitable, or specialist opinion may be needed, in people with liver disease.9
If you develop yellowing of the skin or eyes, dark urine, pale stools, severe itching, right upper abdominal pain, persistent nausea, or marked fatigue after starting a hormone medicine, seek medical advice promptly. Do not stop prescribed contraception or HRT without considering pregnancy risk, symptom rebound and safer alternatives with a clinician.
The tests that matter
A sensible work-up starts with the question: is there evidence of liver injury, fat accumulation, bile-flow obstruction, inflammation, scarring or another cause? Liver blood tests often include ALT, AST, ALP, GGT, bilirubin, albumin and clotting markers, but they do not all mean the same thing. A mildly raised ALT suggests a different pattern from isolated bilirubin, a cholestatic ALP or low albumin.
British Society of Gastroenterology guidance on abnormal liver blood tests emphasises that abnormal results should be interpreted in context and investigated rather than dismissed as "just slightly high".10 For suspected fatty liver, NHS guidance says a GP may ask about symptoms, height, weight, waist measurement and alcohol intake, and may arrange further blood tests or an ultrasound to confirm fat in the liver, rule out other causes and check for damage.2
Private hormone panels can be useful only when they answer a specific question. A single oestrogen metabolite ratio, saliva cortisol graph or broad "liver detox" profile does not replace checking pregnancy status, thyroid function, prolactin, PCOS criteria, iron deficiency, diabetes risk, alcohol intake, medicines and conventional liver assessment.
Safety point: seek urgent advice for jaundice, vomiting blood, black tarry stools, confusion, severe right upper abdominal pain, fever with jaundice, sudden abdominal swelling, or drowsiness in someone with known liver disease.
What actually helps
The best liver-hormone plan is usually metabolic rather than "detox" based. If you have PCOS, perimenopause, menopause, prediabetes, type 2 diabetes, high triglycerides or central weight gain, improving insulin sensitivity can help both liver risk and hormone symptoms. That does not require a perfect diet. It usually means enough protein, a fibre intake you can tolerate, fewer ultra-processed foods, less alcohol, regular resistance training, regular walking, and sleep routines that reduce late-night eating and glucose swings.
NHS advice for NAFLD focuses on a balanced diet, regular exercise, weight loss if overweight, avoiding too much alcohol, and not smoking.2 That advice is simple, but it is not superficial. Losing even a modest amount of excess weight can reduce liver fat in many people, while strength training helps protect muscle during perimenopause and weight loss. Muscle matters because it is a major sink for glucose disposal.
Supplements are weaker evidence. Milk thistle, choline, inositol, berberine, probiotics, DIM, calcium D-glucarate and "liver support" blends are often marketed to women with hormone symptoms. Some may have plausible mechanisms or small trials in specific contexts, but they can also interact with medicines, worsen gastrointestinal symptoms or distract from diagnosis. If a supplement is being used to treat PCOS, menopause symptoms, high liver enzymes or fatty liver, the key question is whether the underlying condition has been properly assessed.
Use internal tools to keep the plan grounded. The wider health library can help you compare liver, metabolic and hormone conditions. Our insights pages are useful for separating mechanisms from marketing. If you are considering supplements after basic checks, the stack builder is a safer way to look for interaction and duplication risks.
What to ask your GP
Go in with a pattern, not a theory. Write down menstrual changes, menopause symptoms, acne or hair growth, bowel changes, itch, sleep, alcohol units, medicine and supplement use, family history, weight or waist change, and any previous liver blood results. If you need help turning this into a focused appointment, use Start here to prepare the problem list before you book.
- Do my symptoms suggest PCOS, perimenopause, thyroid disease, prolactin problems, fibroids, endometriosis, iron deficiency or liver disease?
- Do I need liver blood tests, hepatitis screening, HbA1c, fasting lipids, thyroid function, ferritin, full blood count or pregnancy testing?
- Given my PCOS, menopause status, waist measurement, diabetes risk or blood pressure, should I be assessed for NAFLD or MASLD?
- If liver blood tests are abnormal, should they be repeated, and do I need an ultrasound, fibrosis score, ELF test or hepatology referral?
- Is my contraception or HRT safe with my liver history, and would a non-oral or non-oestrogen option be safer?
Do not let the liver become a dumping ground for unexplained symptoms, but do not ignore it either. Investigate recognised hormone conditions and recognised liver risks together. That is more likely to find the real mechanism than a detox protocol.
References
- Rhyu J, Yu R, 2021. Newly discovered endocrine functions of the liver. World Journal of Hepatology. link
- NHS, reviewed 2025. Non-alcoholic fatty liver disease (NAFLD). link
- NICE, updated 2016. Non-alcoholic fatty liver disease (NAFLD): assessment and management, NG49 recommendations. link
- EASL, EASD, EASO, 2024. Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology. link
- Jaroenlapnopparat A, Charoenngam N, Ponvilawan B, Mariano M, Thongpiya J, Yingchoncharoen P, 2023. Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Menopause. link
- Shengir M, Chen T, Guadagno E, Ramanakumar AV, Ghali P, Deschenes M, Wong P, Krishnamurthy S, Sebastiani G, 2021. Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: a systematic review and meta-analysis. JGH Open. link
- National Institute of Diabetes and Digestive and Kidney Diseases, updated 2020. Estrogens and Oral Contraceptives. LiverTox. link
- NHS, reviewed 2024. Who can take the combined pill. link
- NHS Inform, reviewed 2024. Hormone replacement therapy (HRT). link
- Newsome PN, Cramb R, Davison SM, Dillon JF, Foulerton M, Godfrey EM, Hall R, Harrower U, Hudson M, Langford A, Mackie A, Mitchell-Thain R, Sennett K, Sheron NC, Verne J, Walmsley M, Yeoman A, 2018. Guidelines on the management of abnormal liver blood tests. Gut. link
Nine free tools on this site help you act on what you just read: keep a think-out-loud health journal, prepare a GP appointment, check a supplement stack before buying more, or decode blood results.
Symptom Decoder · Health Journal · GP Script Generator · Stack Risk Checker · Lab Result Primer · Health MOT · All tools. Want it all synced and organised in one private map? The Club, £10/month.
This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.